Lc Laboratories Order Trametinib

Trametinib

HY-10999 100mg
EUR 256.8

Human IgG antibody Laboratories manufactures the lc laboratories order trametinib reagents distributed by Genprice. The Lc Laboratories Order Trametinib reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact LC laboratories. Other Lc products are available in stock. Specificity: Lc Category: Laboratories Group: Order Trametinib

Trametinib (GSK1120212)

10 mM (in 1mL DMSO)
EUR 135.6
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib (GSK1120212)

50 mg
EUR 193.2
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib (GSK1120212)

500 mg
EUR 622.8
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib (GSK1120212)

Evaluation Sample
EUR 97.2
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Custom Peptide Synthesis and Antiibodies Order form

1 Ask for price

Custom Phospho peptide Synthesis and Antiibodies Order form

1 Ask for price

Custom Acetylated peptide Synthesis and Antiibodies Order form

1 Ask for price

Order Trametinib information

Trametinib (GSK1120212)

A3018-50 50 mg
EUR 193.2
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib (GSK1120212)

A3018-500 500 mg
EUR 622.8
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib (GSK1120212)

A3018-S Evaluation Sample
EUR 97.2
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib DMSO solvate

A3887-10 10 mg
EUR 129.6
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib DMSO solvate

A3887-100 100 mg
EUR 224.4
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib DMSO solvate

A3887-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib DMSO solvate

A3887-50 50 mg
EUR 170.4
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib (DMSO solvate)

HY-10999A 100mg
EUR 256.8

Trametinib DMSO solvate

123211 10.0mg
EUR 90

Trametinib (DMSO solvate)

T5857-10mg 10mg Ask for price
Description: Trametinib (DMSO solvate)

Trametinib (DMSO solvate)

T5857-1g 1g Ask for price
Description: Trametinib (DMSO solvate)

Trametinib (DMSO solvate)

T5857-1mg 1mg Ask for price
Description: Trametinib (DMSO solvate)

Trametinib (DMSO solvate)

T5857-50mg 50mg Ask for price
Description: Trametinib (DMSO solvate)

Trametinib (DMSO solvate)

T5857-5mg 5mg Ask for price
Description: Trametinib (DMSO solvate)

OOMC00081-10MG - Trametinib

OOMC00081-10MG 10mg
EUR 59

OOMC00081-50MG - Trametinib

OOMC00081-50MG 50mg
EUR 199

Trametinib dimethyl sulfoxide

414033 25.0mg
EUR 228